Genus plc

LSE:GNS.L

Sector

🛒 Consumer Staples

Industries

🍔 Meat

🌾 Agriculture

🌿 Fertilizers

Location

United Kingdom

Market Cap

USD 1.73 B

Share Price

USD 26.36

Avg Daily Volume

168,222

Change (1 day)

0.90%

Change (1 year)

25.00%

Change (YTD)

35.92%

Genus plc Total Liabilities for the year ending June 30, 2024: USD 613.86 M

Genus plc Total Liabilities is USD 613.86 M for the year ending June 30, 2024, a 9.84% change year over year. Total liabilities are the total amount of a company's debts and other obligations.

Genus plc Total Liabilities for the year ending June 30, 2023 was USD 558.87 M, a 2.97% change year over year.
Genus plc Total Liabilities for the year ending June 30, 2022 was USD 542.78 M, a 10.76% change year over year.
Genus plc Total Liabilities for the year ending June 30, 2021 was USD 490.06 M, a 9.51% change year over year.
Genus plc Total Liabilities for the year ending June 30, 2020 was USD 447.49 M, a 11.37% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Total Liabilities	Shareholders' Equity	Cash and Short-Term Investments	Receivables

LSE: GNS.L

Genus plc

CEO	Mr. Jorgen Kokke
IPO Date	July 6, 2000
Location	United Kingdom
Headquarters	Matrix House
Employees	3,500
Sector	🛒 Consumer Staples
Industries Meat 🌾 Agriculture 🌿 Fertilizers

Description

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in reproductive, and other technical services to farmers. Genus plc has a strategic collaboration with Beijing Capital Agribusiness Co. Ltd to pursue the porcine reproductive respiratory syndrome virus resistant regulatory and development work in China. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.